Bank Of America Corp Cassava Sciences Inc Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Cassava Sciences Inc stock. As of the latest transaction made, Bank Of America Corp holds 116,820 shares of SAVA stock, worth $241,817. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,820

Previous 479,228 75.62%

Holding current value

$241,817

Previous $1.13 Million 84.51%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$1.5 - $3.02 $543,612 - $1.09 Million	-362,408 Reduced 75.62%	116,820 $175,000
Q4 2024 Feb 14, 2025	BUY	$2.29 - $32.18 $889,376 - $12.5 Million	388,374 Added 427.47%	479,228 $1.13 Million
Q3 2024 Nov 14, 2024	SELL	$9.57 - $35.08 $284,583 - $1.04 Million	-29,737 Reduced 24.66%	90,854 $2.67 Million
Q2 2024 Aug 14, 2024	SELL	$12.35 - $26.11 $287,927 - $608,728	-23,314 Reduced 16.2%	120,591 $1.49 Million
Q1 2024 May 15, 2024	SELL	$18.44 - $26.41 $1.66 Million - $2.38 Million	-90,036 Reduced 38.49%	143,905 $2.92 Million
Q4 2023 Feb 14, 2024	BUY	$12.64 - $30.11 $761,319 - $1.81 Million	60,231 Added 34.67%	233,941 $5.27 Million
Q2 2023 Aug 14, 2023	SELL	$21.59 - $27.88 $972,823 - $1.26 Million	-45,059 Reduced 20.6%	173,710 $4.26 Million
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $2.76 Million - $4.29 Million	117,742 Added 116.55%	218,769 $5.28 Million
Q4 2022 Feb 10, 2023	SELL	$27.82 - $44.16 $4.59 Million - $7.29 Million	-164,973 Reduced 62.02%	101,027 $2.98 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $2.02 Million - $6.31 Million	123,547 Added 86.73%	266,000 $11.1 Million
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $1.94 Million - $4.34 Million	112,808 Added 380.53%	142,453 $4.01 Million
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $8 Million - $13 Million	-245,462 Reduced 89.22%	29,645 $1.1 Million
Q4 2021 Feb 08, 2022	BUY	$36.77 - $90.91 $4.54 Million - $11.2 Million	123,437 Added 81.39%	275,107 $12 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $5.32 Million - $17.2 Million	127,274 Added 521.7%	151,670 $9.42 Million
Q2 2021 Sep 13, 2021	BUY	$32.15 - $89.72 $784,331 - $2.19 Million	24,396 New	24,396 $2.09 Million

Others Institutions Holding SAVA

# of Institutions

155

Shares Held

15.6M

Call Options Held

1.67M

Put Options Held

1.26M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $83M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Cassava Sciences Inc Transaction History